Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction

Type 2 diabetes mellitus (T2DM) is associated with a high incidence of non-alcoholic fatty liver disease (NAFLD) related to obesity and insulin resistance. Currently, medical interventions for NAFLD have focused on diet control and exercise to reduce body weight, and there is a requirement for effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Chikara, Tsuchiya, Kyoichiro, Shiba, Kumiko, Miyachi, Yasutaka, Furuke, Shunsaku, Shimazu, Noriko, Yamaguchi, Shinobu, Kanno, Kazuo, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792392/
https://www.ncbi.nlm.nih.gov/pubmed/26977813
http://dx.doi.org/10.1371/journal.pone.0151511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792392/
https://www.ncbi.nlm.nih.gov/pubmed/26977813
http://dx.doi.org/10.1371/journal.pone.0151511

Ejemplares similares